lobbying_activities: 3149921

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3149921	66035456-9c6f-4f6a-9456-13831f8e6be8	Q1	PORT SIDE STRATEGIES, LLC	401105394	NEW VENTURE FUND	2024	first_quarter	PHA	Issues related to implementation of the drug pricing provisions of the Inflation Reduction Act of 2022. H.R.4895 - Lowering Drug Costs for American Families Act - in support. H.R.485 - Protecting Health Care for All Patients Act of 2023 - opposed.	HOUSE OF REPRESENTATIVES,SENATE			0	0	2024-04-17T18:44:11-04:00